Raymond James Financial Services Advisors, Inc. Cerus Corp Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$5.25 - $8.56 $251,637 - $410,289	-47,931 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$5.78 - $7.47 $10,473 - $13,535	1,812 Added 3.93%	47,931 $300,000
Q2 2020 Jul 17, 2020	BUY	$4.5 - $7.02 $207,535 - $323,755	46,119 New	46,119 $304,000

Others Institutions Holding CERS

# of Institutions

156

Shares Held

147M

Call Options Held

84.2K

Put Options Held

55.5K

Baker Bros. Advisors LP New York, NY

19.5M
Shares

$34.9 Million
0.36% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

18.2M
Shares

$32.6 Million
0.3% of portfolio
Black Rock Inc. New York, NY

13.9M
Shares

$24.9 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.8M
Shares

$19.4 Million
0.0% of portfolio
Primecap Management CO Pasadena, CA

8.54M
Shares

$15.3 Million
0.01% of portfolio

View Full List

About CERUS CORP

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $317M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

More about CERS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account